Dexcom G7 is now cleared in the U.S. for people with all Types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution
With an overall MARD
If history is any guide, there may be good fortune ahead for shares of DexCom (NASDAQ:DXCM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Someone with a lot of money to spend has taken a bullish stance on DexCom (NASDAQ:DXCM).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
U.S. stocks closed lower with the Dow Jones dropping more than 600 points on Friday. Here is the list of some big stocks recording gains in the previous session.